Roche, Merck and Lilly are among those calling for regulatory harmonisation and free movement of goods between the EU and the UK once the latter leaves the Union.
Recipharm says three more of its facilities are equipped and ready for US Drug Supply Chain Security Act (DSCSA) serialisation demands, the deadline for which passes today.
Corium says it is in talks with commercialisation partners for its transdermal Alzheimer’s disease candisate Corplex Donepezil ahead of a potential 2019 launch.
Pharma firms making product benefit claims on Twitter must incorporate risk information within the same tweet regardless of character space limitations, says the US FDA.
Interpol has seized more than 300kg of counterfeit pharmaceutical products in West Africa’s Cote d’Ivoire, and uncovered a packaging site for fake medicines.
Pfizer has sold its share of a joint venture with Zhejiang Hisun Pharmaceuticals but will continue supporting the local production of generic drugs in China.
Evoke Pharma has selected Patheon to commercially manufacture its nasal delivery formulation of metoclopramide Gimoti ahead of a planned US FDA submission next year.
Teva has lowered its 2017 guidance on the back of higher-than-expected generic price erosion and lower-than-expected Copaxone sales due to competition.
Pfizer has attributed a 12% operational decline from its sterile injectable products on “capacity constraints and technical issues” stemming from former Hospira facilities.
